Results of a phase II single arm clinical trial assessing efficacy, safety and tolerability of the recombinant Bacillus Calmette Guérin (BCG) VPM1002BC in patients with BCG failure... by C.A. Rentsch, G. Thalmann, I. Lucca, M. Kwiatkowski, G. Wirth, R. Strebel, D. Engeler, A. Pedrazzini, C. Hüttenbrink, W. Schultze-Seemann, L. Bubendorf, A. Wicki, B. Roth, P. Bosshard, H. Püschel, D. Boll, L. Hefermehl, F. Roghmann, M. Gierth, S. Schäfer, S. Hayoz

Get full text